|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||56.48 - 60.60|
|52-week range||52.06 - 71.14|
|Beta (5Y monthly)||1.01|
|PE ratio (TTM)||18.89|
|Forward dividend & yield||1.34 (2.34%)|
|Ex-dividend date||24 May 2021|
|1y target est||N/A|
Fresenius Medical's (FMS) latest dialyzer is expected to better serve dialysis patients because of its design.
FMS earnings call for the period ending September 30, 2021.
Fresenius Medical's (FMS) third-quarter earnings benefit from strong performance across the regions, Asia Pacific and Latin America.